Digital Pathology Market

Market Insights on the Digital Pathology Market, including sales forecast, demand outlook, and key trends

Digital Pathology Market– By Product, Application, End-User & Region - Forecast to 2023-2033

Category: Life Sciences Published Date : Jun-23 ID: CVC-97105 Format: PDF Pages: 300

Report Highlights According to a research survey conducted by ChemView Consulting, the Digital Pathology Market was worth US$ 1050.6 Mn. The market is expected to grow at a CAGR of 7.70% between the 2023 to 2033 to reach US$ 2206.0 Mn.



Report Includes

Research Scope/Taxonomy:

  • Market Analysis by Product:
    • Image Analysis Software
    • Whole Slide Imaging Systems
    • Storage & Communication Systems
    • Scanners
    • Others
  • Market Analysis by Application:
    • Teleconsultation
    • Disease Diagnosis
    • Drug Discovery & Development
    • Training & Education
    • Others
  • Market Analysis by End User:
    • Hospitals
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Research Centers
    • Others
  • Market Analysis by Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

.”







Analyst Credentials

Key Companies Profiled:

  • Philips Healthcare
  • Danaher Corporation
  • PerkinElmer Inc.
  • Leica Biosystems Nussloch GmbH
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology
  • 3DHISTECH Ltd.
  • Visiopharm A/S
  • Mikroscan Technologies, Inc.
  • Indica Labs, Inc.
  • Definiens AG
  • Corista LLC
  • Proscia Inc.
  • Hurricane Medical
  • Objective Pathology Services
  • PathAI
  • Glencoe Software, Inc.
  • DeepBio Inc.
  • ZEISS Group
  • Roche Diagnostics

1.1. Global Market Snapshot

1.2. Key Success Factors

1.3. Strategic Analysis and Recommendations

2.1. Market Taxonomy

2.2. Market Definitions

3.1. Preliminary Investigation & Research Design

3.2. Secondary Research & Primary Research

3.3. Data Analysis & Econometric Modelling

3.4. Expert Data Validation

4.1. Supply-Side Trends

4.2. Demand-Side Trends

5.1. Global Market Value (US$ Mn) Analysis, 2018 – 2033

5.2. Incremental $ Opportunity Index, 2023-2033

5.3. Global Market Volume Analysis, 2018 – 2033

6.1. Regional Level Pricing Analysis and Forecast

6.1.1. Manufacturers Level Pricing

6.1.2. Distributor Level Pricing

6.2. Global Pricing Analysis Benchmark

6.3. Cost Breakdown Analysis

7.1. Cross Analysis of ApplicationW.R.T. Product Type

8.1. Regional Supply Vs. Demand Gap Assessment

8.2. Top Producing Countries Analysis

9.1. Macroeconomic Factors

9.2. Forecast Factors

9.3. Market Dynamics

9.3.1. Driver

9.3.2. Restraint

9.3.3. Opportunity

9.4. Supply Chain Analysis

9.4.1. List Raw Material Suppliers

9.4.2. List of Manufacturers

9.4.3. List of Distributors

9.4.4. List of End-Users

9.4.5. End-Users Consumption Analysis

9.4.6. Average Profitability Margin Analysis

9.5. Covid-19 Impact Assessment

9.5.1. Economy/Cluster Projections

9.5.2. Covid-19 Economic Assessment

9.5.3. Impact on Target Market

9.5.4. Recovery Scenario

9.6. Regulatory Framework

9.6.1. Regulations of Key Countries

9.6.2. Potential Impact of Regulations

9.7. Porter’s Five Forces Analysis

9.8. Technology Landscape

10.1. Introduction

10.2. Key Market Trends

10.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Product [Value (US$ Mn) and Volume Analysis]

10.3.1. Image Analysis Software

10.3.2. Whole Slide Imaging Systems

10.3.3. Storage & Communication Systems

10.3.4. Scanners

10.3.5. Others

10.4. Market Attractiveness Analysis by Product

11.1. Introduction

11.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Application [Value (US$ Mn) and Volume Analysis]

11.2.1. Teleconsultation

11.2.2. Disease Diagnosis

11.2.3. Drug Discovery & Development

11.2.4. Training & Education

11.2.5. Others

11.3. Market Attractiveness Analysis by Application

12.1. Introduction

12.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By End-User [Value (US$ Mn) and Volume Analysis]

12.2.1. Hospitals

12.2.2. Diagnostic Laboratories

12.2.3. Pharmaceutical & Biotechnology Companies

12.2.4. Research Centers

12.2.5. Others

12.3. Market Attractiveness Analysis by End-User

13.1. Introduction

13.2. Key Market Trends

13.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Region [Value (US$ Mn) and Volume Analysis]

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. Asia-Pacific

13.3.5. Middle East

13.3.6. Africa

13.4. Market Attractiveness Analysis by Region

14.1. Introduction

14.2. Key Market Trends

14.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Product

14.3.3. By Application

14.3.4. By End-User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product

14.4.3. By Application

14.4.4. By End-User

15.1. Introduction

15.2. Key Market Trends

15.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Rest of Latin America

15.3.2. By Product

15.3.3. By Application

15.3.4. By End-User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product

15.4.3. By Application

15.4.4. By End-User

16.1. Introduction

16.2. Key Market Trends

16.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. UK

16.3.1.5. Spain

16.3.1.6. Netherlands

16.3.1.7. Norway

16.3.1.8. Russia

16.3.1.9. Rest of Europe

16.3.2. By Product

16.3.3. By Application

16.3.4. By End-User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product

16.4.3. By Application

16.4.4. By End-User

17.1. Introduction

17.2. Key Market Trends

17.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.1.4. India

17.3.1.5. Indonesia

17.3.1.6. Thailand

17.3.1.7. Vietnam

17.3.1.8. Australia & New Zealand

17.3.1.9. Rest of Asia-Pacific

17.3.2. By Product

17.3.3. By Application

17.3.4. By End-User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product

17.4.3. By Application

17.4.4. By End-User

18.1. Introduction

18.2. Key Market Trends

18.3. Pricing Analysis

18.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

18.4.1. By Country

18.4.1.1. Saudi Arabia

18.4.1.2. Turkey

18.4.1.3. U.A.E.

18.4.1.4. Rest of the Middle East

18.4.2. By Product

18.4.3. By Application

18.4.4. By End-User

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Product

18.5.3. By Application

18.5.4. By End-User

19.1. Introduction

19.2. Key Market Trends

19.3. Pricing Analysis

19.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

19.4.1. By Country

19.4.1.1. South Africa

19.4.1.2. Nigeria

19.4.1.3. Egypt

19.4.1.4. Rest of Africa

19.4.2. By Product

19.4.3. By Application

19.4.4. By End-User

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product

19.5.3. By Application

19.5.4. By End-User

20.1. Tier Structure Breakdown

20.2. Market Share Analysis

20.3. Production Capacity Analysis

20.4. Company Footprint Analysis

20.4.1. Product Footprint of Players

20.4.2. Regional Footprint of Players

20.4.3. Channel Footprint of Players

20.5. Brand Preference Analysis

20.6. Competition Dashboard

21.1. Philips Healthcare.

21.1.1. Company Overview

21.1.2. Product & Financial Portfolio

21.1.3. Manufacturing Facilities

21.1.4. Recent Developments

21.1.5. SWOT Analysis

21.1.6. Strategy Overview

21.2. Danaher Corporation

21.3. PerkinElmer Inc.

21.4. Leica Biosystems Nussloch GmbH

21.5. Hamamatsu Photonics K.K.

21.6. Huron Digital Pathology

21.7. 3DHISTECH Ltd.

21.8. Visiopharm A/S

21.9. Mikroscan Technologies, Inc.

21.10. Indica Labs, Inc.

21.11. Definiens AG

21.12. Corista LLC

21.13. Proscia Inc.

21.14. Hurricane Medical

21.15. Objective Pathology Services

21.16. PathAI

21.17. Glencoe Software, Inc.

21.18. DeepBio Inc.

21.19. ZEISS Group

21.20. Roche Diagnostics